Triple-nucleoside regimens versus efavirenz.
作者信息
Maida Ivana, Nuñez Marina, Soriano Vincent
出版信息
N Engl J Med. 2004 Aug 12;351(7):717-9; author reply 717-9.
PMID:15309748
Abstract
摘要
相似文献
1
Triple-nucleoside regimens versus efavirenz.
N Engl J Med. 2004 Aug 12;351(7):717-9; author reply 717-9.
2
Triple-nucleoside regimens versus efavirenz.
N Engl J Med. 2004 Aug 12;351(7):717-9; author reply 717-9. doi: 10.1056/NEJM200408123510720.
3
Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection.
N Engl J Med. 2004 Apr 29;350(18):1850-61. doi: 10.1056/NEJMoa031772.
4
Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.
N Engl J Med. 1999 Dec 16;341(25):1865-73. doi: 10.1056/NEJM199912163412501.
5
A new HAART on the horizon says the proof is in the potency.
AIDS Alert. 1999 Apr;14(4):37-9.
6
7
Efavirenz in HIV infection.
N Engl J Med. 2000 Apr 27;342(17):1290-1. doi: 10.1056/NEJM200004273421713.
8
Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults.
Clin Infect Dis. 2004 Oct 1;39(7):1038-46. doi: 10.1086/424009. Epub 2004 Sep 10.
9
Anatomy of a study: Trizivir vs. Sustiva.
Posit Aware. 2003 May-Jun;14(3):40-1.
10
Zotero 插件